This comprehensive report provides a detailed analysis of the global enuresis treatment drugs market, projecting growth trends from 2025 through 2032. The study examines market dynamics across various regions, including the Americas, APAC, and Europe, while segmenting the industry by drug type, such as Desmopressin, and application settings like hospitals and specialist clinics. Furthermore, the research evaluates competitive landscapes, key player strategies, and emerging opportunities to offer a nuanced view of the industry's future trajectory.

Executive Overview

Global Market Outlook

The global Enuresis Treatment Drugs market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Regional Market Projections

• United States: The market for Enuresis Treatment Drugs in the United States is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.
• China: The market for Enuresis Treatment Drugs in China is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.
• Europe: The market for Enuresis Treatment Drugs in Europe is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.

Report Scope and Methodology

Research Objectives

LPI (LP Information)'s newest research report, titled “Enuresis Treatment Drugs Industry Forecast,” reviews total global Enuresis Treatment Drugs sales in 2025 by looking at past sales data. The report provides a comprehensive analysis of projected Enuresis Treatment Drugs sales for the period of 2026 through 2032, categorized by region and market sector. The study offers a detailed analysis of the world Enuresis Treatment Drugs industry in US$ millions, with sales broken down by region, market sector, and sub-sector.

Analytical Depth

This Insight Report provides a comprehensive analysis of the global Enuresis Treatment Drugs landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on their Enuresis Treatment Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints. This is intended to facilitate a better understanding of these firms’ unique positions within an accelerating global Enuresis Treatment Drugs market.

Market Drivers and Trends

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook for Enuresis Treatment Drugs. It breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory of the global Enuresis Treatment Drugs market. It presents a comprehensive overview, market shares, and growth opportunities by product type, application, key players, and key regions and countries.

Market Segmentation

By Type

• Desmopressin(DDAVP)
• Tofranil
• Others

By Application

• Hospital
• Specialist Clinic
• Others

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Market Share and Key Players

Global key Enuresis Treatment Drugs players include Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., and Urovant Sciences, Inc. In 2025, the global two largest companies occupied a significant portion of the market share.

Profiled Companies

The following companies have been profiled based on inputs gathered from primary experts and an analysis of their coverage, product portfolio, and market penetration:

• Allergan
• Ferring Pharmaceuticals, Inc.
• Pfizer Inc.
• Janssen Pharmaceuticals, Inc.
• Urovant Sciences, Inc.
• Astellas Pharma US, Inc.
• Bayer Corp
• Mallinckrodt, Inc.
• Shanghai Xudong Haipu Pharmaceutical Co., Ltd
• Guangdong Xianqiang Pharmaceutical Co., Ltd
• Beijing Zizhu Pharmaceutical Co., Ltd
• Shanghai Pharmaceutical Group

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Enuresis Treatment Drugs Market Size (2021-2032)

    • 2.1.2 Enuresis Treatment Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Enuresis Treatment Drugs by Country/Region (2021, 2025 & 2032)

  • 2.2 Enuresis Treatment Drugs Segment by Type

    • 2.2.1 Desmopressin(DDAVP)

    • 2.2.2 Tofranil

    • 2.2.3 Others

    • 2.2.4 Enuresis Treatment Drugs Market Size by Type

      • 2.2.4.1 Enuresis Treatment Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.4.2 Global Enuresis Treatment Drugs Market Size Market Share by Type (2021-2026)

  • 2.3 Enuresis Treatment Drugs Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Specialist Clinic

    • 2.3.3 Others

    • 2.3.4 Enuresis Treatment Drugs Market Size by Application

      • 2.3.4.1 Enuresis Treatment Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.4.2 Global Enuresis Treatment Drugs Market Size Market Share by Application (2021-2026)

• 3 Enuresis Treatment Drugs Market Size by Player

  • 3.1 Enuresis Treatment Drugs Market Size Market Share by Player

    • 3.1.1 Global Enuresis Treatment Drugs Revenue by Player (2021-2026)

    • 3.1.2 Global Enuresis Treatment Drugs Revenue Market Share by Player (2021-2026)

  • 3.2 Global Enuresis Treatment Drugs Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Enuresis Treatment Drugs by Region

  • 4.1 Enuresis Treatment Drugs Market Size by Region (2021-2026)

  • 4.2 Global Enuresis Treatment Drugs Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Enuresis Treatment Drugs Market Size Growth (2021-2026)

  • 4.4 APAC Enuresis Treatment Drugs Market Size Growth (2021-2026)

  • 4.5 Europe Enuresis Treatment Drugs Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Enuresis Treatment Drugs Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Enuresis Treatment Drugs Market Size by Country (2021-2026)

  • 5.2 Americas Enuresis Treatment Drugs Market Size by Type (2021-2026)

  • 5.3 Americas Enuresis Treatment Drugs Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Enuresis Treatment Drugs Market Size by Region (2021-2026)

  • 6.2 APAC Enuresis Treatment Drugs Market Size by Type (2021-2026)

  • 6.3 APAC Enuresis Treatment Drugs Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Enuresis Treatment Drugs Market Size by Country (2021-2026)

  • 7.2 Europe Enuresis Treatment Drugs Market Size by Type (2021-2026)

  • 7.3 Europe Enuresis Treatment Drugs Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Enuresis Treatment Drugs by Region (2021-2026)

  • 8.2 Middle East & Africa Enuresis Treatment Drugs Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Enuresis Treatment Drugs Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Enuresis Treatment Drugs Market Forecast

  • 10.1 Global Enuresis Treatment Drugs Forecast by Region (2027-2032)

    • 10.1.1 Global Enuresis Treatment Drugs Forecast by Region (2027-2032)

    • 10.1.2 Americas Enuresis Treatment Drugs Forecast

    • 10.1.3 APAC Enuresis Treatment Drugs Forecast

    • 10.1.4 Europe Enuresis Treatment Drugs Forecast

    • 10.1.5 Middle East & Africa Enuresis Treatment Drugs Forecast

  • 10.2 Americas Enuresis Treatment Drugs Forecast by Country (2027-2032)

    • 10.2.1 United States Market Enuresis Treatment Drugs Forecast

    • 10.2.2 Canada Market Enuresis Treatment Drugs Forecast

    • 10.2.3 Mexico Market Enuresis Treatment Drugs Forecast

    • 10.2.4 Brazil Market Enuresis Treatment Drugs Forecast

  • 10.3 APAC Enuresis Treatment Drugs Forecast by Region (2027-2032)

    • 10.3.1 China Enuresis Treatment Drugs Market Forecast

    • 10.3.2 Japan Market Enuresis Treatment Drugs Forecast

    • 10.3.3 Korea Market Enuresis Treatment Drugs Forecast

    • 10.3.4 Southeast Asia Market Enuresis Treatment Drugs Forecast

    • 10.3.5 India Market Enuresis Treatment Drugs Forecast

    • 10.3.6 Australia Market Enuresis Treatment Drugs Forecast

  • 10.4 Europe Enuresis Treatment Drugs Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Enuresis Treatment Drugs Forecast

    • 10.4.2 France Market Enuresis Treatment Drugs Forecast

    • 10.4.3 UK Market Enuresis Treatment Drugs Forecast

    • 10.4.4 Italy Market Enuresis Treatment Drugs Forecast

    • 10.4.5 Russia Market Enuresis Treatment Drugs Forecast

  • 10.5 Middle East & Africa Enuresis Treatment Drugs Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Enuresis Treatment Drugs Forecast

    • 10.5.2 South Africa Market Enuresis Treatment Drugs Forecast

    • 10.5.3 Israel Market Enuresis Treatment Drugs Forecast

    • 10.5.4 Turkey Market Enuresis Treatment Drugs Forecast

  • 10.6 Global Enuresis Treatment Drugs Forecast by Type (2027-2032)

  • 10.7 Global Enuresis Treatment Drugs Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Enuresis Treatment Drugs Forecast

• 11 Key Players Analysis

  • 11.1 Allergan

    • 11.1.1 Allergan Company Information

    • 11.1.2 Allergan Enuresis Treatment Drugs Product Offered

    • 11.1.3 Allergan Enuresis Treatment Drugs Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Allergan Main Business Overview

    • 11.1.5 Allergan Latest Developments

  • 11.2 Ferring Pharmaceuticals, Inc.

    • 11.2.1 Ferring Pharmaceuticals, Inc. Company Information

    • 11.2.2 Ferring Pharmaceuticals, Inc. Enuresis Treatment Drugs Product Offered

    • 11.2.3 Ferring Pharmaceuticals, Inc. Enuresis Treatment Drugs Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Ferring Pharmaceuticals, Inc. Main Business Overview

    • 11.2.5 Ferring Pharmaceuticals, Inc. Latest Developments

  • 11.3 Pfizer Inc.

    • 11.3.1 Pfizer Inc. Company Information

    • 11.3.2 Pfizer Inc. Enuresis Treatment Drugs Product Offered

    • 11.3.3 Pfizer Inc. Enuresis Treatment Drugs Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Pfizer Inc. Main Business Overview

    • 11.3.5 Pfizer Inc. Latest Developments

  • 11.4 Janssen Pharmaceuticals, Inc.

    • 11.4.1 Janssen Pharmaceuticals, Inc. Company Information

    • 11.4.2 Janssen Pharmaceuticals, Inc. Enuresis Treatment Drugs Product Offered

    • 11.4.3 Janssen Pharmaceuticals, Inc. Enuresis Treatment Drugs Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Janssen Pharmaceuticals, Inc. Main Business Overview

    • 11.4.5 Janssen Pharmaceuticals, Inc. Latest Developments

  • 11.5 Urovant Sciences, Inc.

    • 11.5.1 Urovant Sciences, Inc. Company Information

    • 11.5.2 Urovant Sciences, Inc. Enuresis Treatment Drugs Product Offered

    • 11.5.3 Urovant Sciences, Inc. Enuresis Treatment Drugs Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Urovant Sciences, Inc. Main Business Overview

    • 11.5.5 Urovant Sciences, Inc. Latest Developments

  • 11.6 Astellas Pharma US, Inc.

    • 11.6.1 Astellas Pharma US, Inc. Company Information

    • 11.6.2 Astellas Pharma US, Inc. Enuresis Treatment Drugs Product Offered

    • 11.6.3 Astellas Pharma US, Inc. Enuresis Treatment Drugs Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Astellas Pharma US, Inc. Main Business Overview

    • 11.6.5 Astellas Pharma US, Inc. Latest Developments

  • 11.7 Bayer Corp

    • 11.7.1 Bayer Corp Company Information

    • 11.7.2 Bayer Corp Enuresis Treatment Drugs Product Offered

    • 11.7.3 Bayer Corp Enuresis Treatment Drugs Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Bayer Corp Main Business Overview

    • 11.7.5 Bayer Corp Latest Developments

  • 11.8 Mallinckrodt, Inc.

    • 11.8.1 Mallinckrodt, Inc. Company Information

    • 11.8.2 Mallinckrodt, Inc. Enuresis Treatment Drugs Product Offered

    • 11.8.3 Mallinckrodt, Inc. Enuresis Treatment Drugs Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Mallinckrodt, Inc. Main Business Overview

    • 11.8.5 Mallinckrodt, Inc. Latest Developments

  • 11.9 Shanghai Xudong Haipu Pharmaceutical Co., Ltd

    • 11.9.1 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Company Information

    • 11.9.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Enuresis Treatment Drugs Product Offered

    • 11.9.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Enuresis Treatment Drugs Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Main Business Overview

    • 11.9.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd Latest Developments

  • 11.10 Guangdong Xianqiang Pharmaceutical Co., Ltd

    • 11.10.1 Guangdong Xianqiang Pharmaceutical Co., Ltd Company Information

    • 11.10.2 Guangdong Xianqiang Pharmaceutical Co., Ltd Enuresis Treatment Drugs Product Offered

    • 11.10.3 Guangdong Xianqiang Pharmaceutical Co., Ltd Enuresis Treatment Drugs Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Guangdong Xianqiang Pharmaceutical Co., Ltd Main Business Overview

    • 11.10.5 Guangdong Xianqiang Pharmaceutical Co., Ltd Latest Developments

  • 11.11 Beijing Zizhu Pharmaceutical Co., Ltd

    • 11.11.1 Beijing Zizhu Pharmaceutical Co., Ltd Company Information

    • 11.11.2 Beijing Zizhu Pharmaceutical Co., Ltd Enuresis Treatment Drugs Product Offered

    • 11.11.3 Beijing Zizhu Pharmaceutical Co., Ltd Enuresis Treatment Drugs Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 Beijing Zizhu Pharmaceutical Co., Ltd Main Business Overview

    • 11.11.5 Beijing Zizhu Pharmaceutical Co., Ltd Latest Developments

  • 11.12 Shanghai Pharmaceutical Group

    • 11.12.1 Shanghai Pharmaceutical Group Company Information

    • 11.12.2 Shanghai Pharmaceutical Group Enuresis Treatment Drugs Product Offered

    • 11.12.3 Shanghai Pharmaceutical Group Enuresis Treatment Drugs Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Shanghai Pharmaceutical Group Main Business Overview

    • 11.12.5 Shanghai Pharmaceutical Group Latest Developments

• 12 Research Findings and Conclusion